Intravitreal aflibercept for diabetic macular oedema: Moorfields’ real-world 12-month visual acuity and anatomical outcomesMarko Lukić, Ranjan Rajendram, Robin Hamilton et al.|European Journal of Ophthalmology|2019Cited by 35
Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomesMarko Lukić, Ranjan Rajendram, Gwyn Samuel Williams et al.|European Journal of Ophthalmology|2020Cited by 29
Retina‐Specific mRNA in the Assessment of Diabetic RetinopathyZaid Shalchi, R. Swaminathan, Harmanjit Sandhu et al.|Annals of the New York Academy of Sciences|2008Cited by 22
Circulating Nucleic Acids and Diabetic ComplicationsAsif N. Butt, R. Swaminathan, Zaid Shalchi et al.|Annals of the New York Academy of Sciences|2006Cited by 21
Towards a blood test for diabetic retinopathyZaid Shalchi, R. Swaminathan, Susan Smith et al.|Acta Ophthalmologica|2008Cited by 0